VolitionRX Limited (NYSEAMERICAN:VNRX - Get Free Report) shares crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.70 and traded as low as $0.64. VolitionRX shares last traded at $0.69, with a volume of 104,343 shares.
VolitionRX Trading Down 1.5%
The company has a market cap of $70.48 million, a P/E ratio of -2.62 and a beta of 1.27. The company has a 50 day moving average price of $0.69.
About VolitionRX
(
Get Free Report)
VolitionRx Limited, a multi-national epigenetics company, engages in the development of blood tests to help diagnose and monitor a range of cancers, and sepsis and COVID-19 in the United States and internationally. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets for monitoring the immune system; Nu.Q Cancer for monitoring disease progression, response to treatment and minimal residual disease; Capture-PCR, an isolating and capturing circulating tumor derived DNA from plasma samples for early cancer detection; and Nu.Q Discover, a solution to profiling nucleosomes.
Featured Articles
Before you consider VolitionRX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and VolitionRX wasn't on the list.
While VolitionRX currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
